THOUSAND OAKS, Calif., June 1 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia ...
An Amgen sign is seen at the company's office in South San Francisco (Reuters) - The U.S. Food and Drug Administration added a serious warning on the prescribing information for Amgen's drug Prolia to ...
Approvals expand Amneal’s biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback